Analyst Ratings for Mineralys Therapeutics, Inc. (MLYS)
MLYS Rating Summary
MLYS Price Target Summary
- Highest: $55.00 (Wells Fargo)
- Lowest: $26.00 (Jefferies)
- Average: $45.60
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$45.60 (+71.5%)
* Over Last 12-Mos
Rating Score: 9 / 10
Percentile Rank: 89%
Rating Score: 9 / 10
Percentile Rank: 89%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/11/2025 | Jefferies » Updated 9/3/2025 |
Dennis Ding | New Coverage | Hold (N/A) |
26.00 (15.00) |
16.19 (26.59) |
64.24% | Details |
| 7/10/2024 | H.C. Wainwright » Updated 10/30/2025 |
Matthew Caufield | New Coverage | Buy (N/A) |
52.00 (42.00) |
12.89 (26.59) |
106.28% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
